Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse (multiple letters) [1]

Leukemia

Volumn 18, Issue 10, 2004, Pages 1727-1729

  von Stackelberg, Arend ^a   Seeger, K ^a   Henze, G ^a   Eckert, C ^a   Coustan Smith, E ^b   Campana, D ^b,c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN; T LYMPHOCYTE RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CHILDHOOD LEUKEMIA; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; FEASIBILITY STUDY; FLOW CYTOMETRY; GENE REARRANGEMENT; HUMAN; IMMUNOPHENOTYPING; INTERMETHOD COMPARISON; LETTER; MINIMAL RESIDUAL DISEASE; MOLECULAR GENETICS; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; STEM CELL TRANSPLANTATION; TIME MANAGEMENT;

EID: 6344243572     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403475     Document Type: Letter

References (0)